---

Soft Tissue Flaps in Orthopaedics - Complete Guide for Postgraduate Exams

---

1. BASIC DEFINITION

• This is the key difference from a skin graft - a graft has NO blood supply of its own; it depends entirely on the recipient bed
• A flap brings its own vasculature, so it can survive even on poor recipient beds (infected wounds, exposed bone/hardware, irradiated tissue)

---

2. FLAP vs. GRAFT - KEY COMPARISON

---

3. THE RECONSTRUCTIVE LADDER

1. Supportive measures (dressings, NPWT)
2. Direct primary closure
3. Skin graft (split or full thickness)
4. Local flaps
5. Regional flaps
6. Free tissue transfer (free flap)

The reconstructive ladder is not always followed rigidly. For complex high-energy injuries, jumping directly to free flap (sometimes called the "reconstructive elevator") gives better outcomes than using a local flap that may lie in the zone of injury.

---

4. CLASSIFICATION OF FLAPS

A. By Blood Supply (Most Important)

1. Random Pattern Flap

• Blood supply from the subdermal plexus (unnamed capillaries)
• No specific vessel is included in the pedicle
• Limited by length-to-breadth ratio - for lower limb: 1:1 or maximum 2:1 (risk of tip necrosis if longer)
• Examples: rotation flap, transposition flap, advancement flap on the trunk

2. Axial Pattern Flap

• Blood supply from a named, anatomically constant artery incorporated into the flap's base
• Can be much longer than random flaps because direct arterial input
• Examples: groin flap (superficial circumflex iliac artery), dorsalis pedis flap
• Ponten's "super flap" (1981) - including the deep fascia in lower limb flaps dramatically improved their length and survival - this was the birth of fasciocutaneous flaps

3. Perforator Flap

• Blood supply via perforator vessels that pass through (or around) deeper structures (muscle or fascia) to reach skin
• Named after the source vessel, e.g., anterolateral thigh (ALT) flap (perforators from lateral circumflex femoral artery)
• Advantage: harvest skin/fat without sacrificing muscle = less donor site morbidity
• Examples: ALT flap, deep inferior epigastric perforator (DIEP) flap

---

B. By Tissue Composition

---

C. By Method of Movement

1. Advancement Flap

• Tissue moves directly forward into the defect
• No rotation or lateral movement
• Example: V-Y advancement flap of fingertip

2. Rotation Flap

• Tissue swings in a curved arc around a pivot point
• The flap is semicircular
• Used for scalp, sacral pressure sores

3. Transposition Flap

• Tissue moves laterally over intact skin between donor and recipient
• Creates a secondary defect that must be closed (skin grafted or direct closure)
• Example: Z-plasty, rhomboid flap

4. Interpolation Flap

• Flap is raised from an area not adjacent to the defect - passes over or under intact skin
• Usually a 2-stage procedure (pedicle divided at 3 weeks)
• Example: cross-leg flap (historical), paramedian forehead flap

5. Propeller Flap (Island Flap Variant)

• A perforator-based island flap rotated around its perforator by up to 180 degrees
• Used for defects around ankle and distal leg

---

D. By Location of Donor Site

---

5. MATHES AND NAHAI CLASSIFICATION OF MUSCLE FLAPS (Vascular Anatomy)

Key point: Types I, II, and V are most reliable for pedicled transfer because they have a dominant single or dual supply. Type IV (segmental) flaps like sartorius are unreliable - division at one end causes ischemia.

---

6. SPECIFIC FLAPS IN ORTHOPAEDIC PRACTICE

The "Rule of Thirds" for Tibial Coverage (Most Tested!)

---

A. Gastrocnemius Flap

• Type I Mathes-Nahai (single dominant pedicle - sural artery, branch of popliteal)
• Two heads (medial and lateral) - medial head is larger and more commonly used
• Arc of rotation: covers proximal tibia, knee, lower patellar region
• Key steps: Medial incision along posterior leg, identify and protect great saphenous vein and saphenous nerve, detach distal insertion, rotate flap anteriorly, apply split skin graft on top
• Indications: Proximal tibial fractures (Gustilo IIIB), knee joint exposure after arthroplasty infection, patellar/extensor mechanism reconstruction
• Used as pedicled flap - not typically for free flap
• The lateral head has a smaller arc and is less used

B. Soleus Flap

• Type II Mathes-Nahai (dominant pedicle from posterior tibial artery proximally + segmental branches)
• Covers the middle third of tibia
• Harder to raise than gastrocnemius (less tissue bulk, awkward dissection, must preserve segmental feeders)
• Can be split and turned as a "hemisoleus" flap based on medial or lateral half
• Arc of rotation is limited - does not reach proximal or distal tibia well
• The reverse soleus flap (distally-based, retrograde flow) can cover the distal third but is less reliable

C. Anterolateral Thigh (ALT) Flap

• Workhorse free flap for lower extremity and head and neck
• Based on perforators from the descending branch of the lateral circumflex femoral artery
• Can provide large amounts of skin and fat
• Can be thinned, used as fasciocutaneous or musculocutaneous component
• Donor site often closed primarily if <8 cm wide
• Used for: distal tibial defects, foot/ankle, upper limb coverage

D. Latissimus Dorsi Flap

• Type V Mathes-Nahai (dominant thoracodorsal artery + secondary segmental vessels)
• Largest single flap in the body - can cover massive defects
• Used as pedicled (for chest wall, axilla, shoulder) or free flap (for lower leg, foot, distal extremities)
• When used as pedicled: thoracodorsal pedicle preserved; arc covers shoulder/chest
• When used as free flap: thoracodorsal vessels anastomosed to recipient vessels

E. Radial Forearm Flap

• Fasciocutaneous axial flap based on radial artery
• Thin, pliable, and reliable
• Used as free flap for hand, foot, lower extremity, head and neck
• Allen's test must be performed preoperatively to ensure ulnar artery collateral adequacy
• Can include palmaris longus tendon as tendocutaneous flap

F. Gracilis Flap

• Type II Mathes-Nahai
• Pedicle from the medial circumflex femoral artery
• Relatively small but can be used for: perineal reconstruction, thigh defects, functioning muscle transfer (e.g., for facial reanimation, Volkmann's contracture)
• Low donor site morbidity (hip adduction not significantly impaired)

G. Free Fibula Flap

• Osseocutaneous free flap
• Based on peroneal artery and its perforators
• Standard reconstruction for large bone defects (>6 cm) - mandible, tibia, femur, radius
• Up to 25-26 cm of bone can be harvested
• Skin paddle available for soft tissue cover
• Must assess vascularity with angiogram/Doppler - ensure posterior tibial or anterior tibial artery is adequate before sacrifice of peroneal artery

H. Sural Artery Flap (Reverse Sural Flap)

• Based on distally-based pedicle from the sural nerve and small saphenous vein
• A reverse-flow (retrograde) flap - blood flows backward through anastomotic connections from the peroneal artery
• Covers the distal leg, heel, and ankle where free flap infrastructure may not be available
• Arc of pivot point: 5 cm above the lateral malleolus
• Risk of venous congestion (commonest complication)

I. Cross-Leg Flap (Historical)

• Pedicled flap from one leg transferred to defect on other leg
• 3-6 weeks for pedicle division
• Now largely replaced by free flaps
• Still used in centers without microvascular capability

---

7. FREE FLAP SURGERY (Free Tissue Transfer)

What is it?

• Flap is completely detached from donor site - arteries and veins are divided
• Donor vessels anastomosed (microsurgery) to recipient vessels near the defect
• Requires operating microscope, microsurgical training

Advantages over pedicled flaps

• Can reach any defect in the body
• Not constrained by arc of rotation or pedicle length
• Better tissue match possible
• Preferred for Gustilo IIIB tibial fractures with large soft tissue defects - lower complication rate than local/regional flaps for severe injuries (Pollak et al. - 4.3x more likely to have operative wound complication with rotational flap for OTA Type C fractures)

Prerequisites for Free Flap Success (Four Pillars)

1. A well-prepared patient - optimized nutrition, no active coagulopathy
2. Complete surgical plan - recipient vessels identified, flap selected, second team available
3. Well-equipped operating environment - microscope, vascular instruments, anastomosis sutures (8-0, 9-0 nylon)
4. Safe postoperative environment - flap monitoring, anticoagulation protocol

Common Free Flaps in Orthopaedics

---

8. FASCIOCUTANEOUS FLAP CLASSIFICATION (Cormack and Lamberty)

---

9. TIMING OF SOFT TISSUE COVERAGE

• Ideal: Within 72 hours of injury (early coverage reduces infection, flap failure, nonunion, and osteomyelitis)
• Maximum: Within 7 days - coverage beyond 7 days significantly increases infection rates
  • One study (Bhattacharya): 12.5% infection rate with coverage <7 days vs. 57% with >7 days
  • Even with NPWT, delay beyond 7 days remains dangerous
• "Time from definitive fixation to flap coverage" is more important than "time from injury to coverage"
• Tissue necrosis and nosocomial contamination are the enemy of delayed coverage

NPWT (Negative Pressure Wound Therapy)

• Useful bridging measure before definitive flap
• Reduces wound edema, promotes granulation tissue
• NOT a substitute for definitive flap coverage
• Does NOT reduce overall infection rates in open tibial fractures when used to delay definitive coverage

---

10. VASCULAR ANATOMY AND FLAP FAILURE

• Venous congestion is the most common cause of flap failure (especially in lower extremity)
• Lower extremity flaps are more prone to venous stasis than upper extremity
• Preoperative angiogram should be considered - Stranix et al. found 52% arterial injury in limbs with Gustilo IIIB/C fractures
• Risk of flap failure by vessel runoff:
  • 3-vessel runoff: baseline
  • 2-vessel runoff: 1.6x greater risk of failure
  • 1-vessel runoff: 2.2x greater risk
• Having 2 vein outflow anastomoses reduces complication rates 4-fold vs. single vein anastomosis

---

11. ZONE OF INJURY CONCEPT

• In high-energy trauma, the visible wound underestimates the actual zone of injured tissue
• Local/regional flaps elevated from within the zone of injury may appear healthy but have compromised microvasculature
• This is why free flaps from distant sites are preferred for severe injuries - donor tissue is outside the zone of injury
• Rotational flap in zone of injury: 4.3x more likely to have operative wound complication (Pollak et al.)

---

12. COMPLICATIONS OF FLAPS

---

13. MONITORING FREE FLAPS (Postoperative)

• Check every 1-2 hours in immediate postoperative period
• Clinical signs to assess:
  • Color: pink = normal; pale = arterial problem; purple/blue/congested = venous problem
  • Temperature: warm = well perfused
  • Capillary refill: <2 seconds normal
  • Turgor/turgidity
• Doppler signal: handheld Doppler over the pedicle or skin paddle perforator
• Implantable Dopplers: used for deep flaps
• Early re-exploration (within 6-8 hours of compromise) salvages most failing flaps
• Venous congestion: medicinal leeches can buy time while revision surgery planned

---

14. SPECIFIC ORTHOPAEDIC SCENARIOS

Open Tibial Fracture Gustilo IIIB

• Requires flap coverage (by definition)
• Proximal third: Gastrocnemius flap
• Middle third: Soleus flap
• Distal third: Free ALT or latissimus dorsi
• Coverage within 7 days (ideally 72 hours)

Infected Total Knee Arthroplasty with Wound Breakdown

• Gastrocnemius flap is the workhorse for periprosthetic soft tissue coverage around the knee
• Medial head preferred (larger)
• Used after debridement +/- hardware removal

Calcaneal/Heel Defects

• Challenging area - weight-bearing, specialized tissue
• Options: Reverse sural flap, free ALT, instep flap
• Requires durable, sensate coverage ideally

Mangled Extremity

• Assess with MESS (Mangled Extremity Severity Score) - score ≥7 = amputation
• If salvage attempted: early orthoplastic approach, free flap preferred
• Preoperative angiography/CT angiography essential

---

15. THE ORTHOPLASTIC APPROACH

• Orthoplastic = Orthopaedic + Plastic Surgery working together from Day 1
• Evidence shows superior outcomes (lower infection, lower flap failure, better functional results) compared to sequential treatment
• Key principle: Orthopaedic surgeon does bony fixation, plastic surgeon does soft tissue coverage - planned together, often in same sitting
• Reduces multiple anesthetics, shortens hospital stay, better resource use

---

16. QUICK MEMORY AIDS FOR EXAM

Reconstructive Ladder (bottom to top):

• Supportive → Direct closure → sLit-skin graft → Local flap → Regional flap → Free flap

Rule of Thirds for Tibia:

• Proximal = Gastrocnemius (P-G)
• Middle = Soleus (M-S)
• Distal = Free flap (D-F)

Mathes-Nahai Types (1-5):

• Type 1: 1 pedicle (Gastrocnemius, TFL)
• Type 2: 2 pedicles - 1 dominant + 1 minor (Gracilis, Soleus)
• Type 3: 3 - 2 dominant (Gluteus max, Rectus abdominis)
• Type 4: 4 = Four or more Segmental vessels (Sartorius - least reliable)
• Type 5: 5 = 1 dominant + many secondary segments (Latissimus dorsi, Pec major)

---

SOURCES

• Rockwood and Green's Fractures in Adults, 10th Ed 2025 - Chapter on Soft Tissue Coverage, pp. 715-740
• Miller's Review of Orthopaedics, 9th Ed - Open Fracture Coverage Guidelines, pp. 894-895
• Campbell's Operative Orthopaedics, 15th Ed 2026 - Free Soft-Tissue Transfer
• Medscape: Tissue Flaps Classification and Principles
• The Plastics Fella: Classification of Flaps

---

Osteoporosis - Complete Guide for Orthopaedic Postgraduate Exams

---

1. DEFINITION

• Low bone mineral density (BMD)
• Microarchitectural deterioration of bone tissue
• Reduced bone strength leading to increased fracture risk

---

2. T-SCORE AND Z-SCORE (Most Tested!)

T-Score (WHO Diagnostic Criteria)

Risk increases 1.5 to 3.0 fold for every 1 standard deviation drop in BMD

Z-Score

• Used in premenopausal women, men <50 years, and children
• Z-score below -2.0 = "below expected range for age" - suggests secondary cause

Measurement Site

• Gold standard measurement: Lumbar spine L2-L4 and femoral neck (hip)
• Most commonly used in clinical practice: Dual Energy X-ray Absorptiometry (DEXA/DXA)

---

3. CLASSIFICATION

Type I - Postmenopausal Osteoporosis

• Women within 15-20 years of menopause (age 51-75)
• Due to estrogen deficiency accelerating osteoclast activity
• Primarily affects trabecular (cancellous) bone
• Fractures: Vertebral bodies and distal radius most common
• 6-fold increase in bone loss rate after menopause

Type II - Senile (Age-Related) Osteoporosis

• Patients older than 70 years (both men and women - ratio 2:1 female:male)
• Due to age-related decline in bone formation + decreased calcium absorption
• Affects both cortical and trabecular bone
• Fractures: Hip fractures most common
• Men also affected - often underdiagnosed and undertreated

Secondary Osteoporosis

• Due to an identifiable underlying cause (see risk factors section)

---

4. EPIDEMIOLOGY (Numbers to Remember)

• Most common bone disease worldwide
• Responsible for >1 million fractures per year
• Most common fracture site = vertebral body
• Lifetime fracture risk in White women >50 years = 75%
• Risk of hip fracture in women = 15-20%
• Risk of second vertebral fracture after first = 20%
• Vertebral fracture increases 5-year mortality by 15%
• Lifetime fracture risk: women ~53%, men ~21%
• Most fractures occur NOT in osteoporotic patients but in osteopenic patients (because there are far more osteopenic patients in the population)

---

5. PATHOPHYSIOLOGY

• Osteoclasts resorb old bone → Osteoblasts form new bone
• Normally coupled and balanced

• Osteoclast activity > Osteoblast activity (imbalance)
• Net result: bone is lost over time

How Estrogen Protects Bone

• Estrogen inhibits osteoclasts (by suppressing RANKL/OPG system)
• After menopause: estrogen falls → RANKL rises → osteoclast activity surges → rapid bone loss
• This is why postmenopausal women are at highest risk

The RANKL-OPG Axis (Key Molecular Pathway)

• RANKL (Receptor Activator of Nuclear Factor Kappa B Ligand) - promotes osteoclast formation and activation
• OPG (Osteoprotegerin) - decoy receptor, blocks RANKL, inhibits osteoclast formation
• RANK - receptor on osteoclast precursors; when RANKL binds to it, osteoclasts are activated
• In osteoporosis: RANKL >> OPG → excess osteoclast activity
• Denosumab drug mechanism: monoclonal antibody that binds and neutralizes RANKL

Bone Peaks and Declines

• Peak bone mass reached at age 25-30 years
• Genetic factors account for 70-85% of variance in bone mass
• Women lose bone rapidly in the first 5-10 years after menopause (up to 3% per year)
• After age 65-70, men catch up in terms of bone loss rate

Microstructural Changes (Histology)

• Thinning of trabeculae
• Decreased osteon size
• Enlarged Haversian canals and marrow spaces
• Cortical bone becomes thinner
• Trabecular connectivity is lost (perforation of trabeculae) - makes bone weaker out of proportion to the BMD loss

---

6. RISK FACTORS

Non-Modifiable

• Female sex
• Age >50
• White race / Northern European descent (fair skin and hair)
• Family history of osteoporosis or hip fracture
• Personal history of previous fracture
• Early menopause (<45 years)
• Small body frame / low BMI (<19 kg/m²)

Modifiable Lifestyle Factors

• Smoking (earlier menopause, accelerated estrogen metabolism)
• Alcohol >3 units/day (multifactorial - direct bone toxicity + fall risk)
• Sedentary lifestyle (mechanical loading increases bone mass; immobility causes bone loss)
• Low calcium and Vitamin D intake
• Heavy cannabis use (affects osteoclast and osteoblast via cannabinoid receptors)

Diseases Causing Secondary Osteoporosis

Drugs Causing Secondary Osteoporosis (MOST TESTED!)

1. Corticosteroids - #1 cause of drug-induced osteoporosis; reduces calcium absorption, increases renal calcium loss, causes osteoblast apoptosis
2. Thyroxine (excess replacement)
3. GnRH agonists (e.g., leuprolide - used in prostate cancer) - cause hypogonadism
4. Anticonvulsants (phenytoin - impairs Vitamin D metabolism)
5. Heparin (long-term)
6. SSRIs (mechanism unclear - direct bone cell effects + fall risk)
7. Benzodiazepines (increased falls + direct bone effects)
8. Proton pump inhibitors (PPIs) - impair calcium absorption
9. Aromatase inhibitors (used in breast cancer - reduce estrogen)
10. Chemotherapy agents

---

7. CLINICAL FEATURES

Silent Until Fracture

• Osteoporosis itself causes no pain and no symptoms
• Diagnosed incidentally or after fracture

Fragility Fracture

• Definition: fracture from a fall from standing height or less (low-energy mechanism that should NOT break a normal bone)
• Common sites: Hip, vertebra, wrist (Colles), humerus, pelvis, ribs

Vertebral Fracture Features

• Most common type of osteoporotic fracture
• Often asymptomatic (two-thirds go undiagnosed)
• Symptomatic: acute back pain (localised or radiating - can mimic angina or acute abdomen)
• Insidious presentation: progressive height loss, kyphosis, chronic back pain
• Deformity patterns:
  • Anterior wedge fracture (most common) - at T11-L1
  • Biconcave/codfish vertebra - central endplate depression due to disc herniation into soft bone
  • Crush fracture - complete vertebral collapse
• Each vertebral fracture shortens height by ~1 cm
• Risk of another vertebral fracture after the first = 20% (high immediate risk)

Hip Fracture

• Most devastating consequence - 1-year mortality 20-30%
• Intertrochanteric > femoral neck in Type II (senile)
• Femoral neck > intertrochanteric in Type I (postmenopausal)

Distal Radius Fracture (Colles)

• Often first manifestation in Type I osteoporosis (younger postmenopausal women)

---

8. INVESTIGATIONS

1. DEXA Scan (Dual Energy X-ray Absorptiometry)

• Gold standard for diagnosing and monitoring osteoporosis
• Measures BMD at lumbar spine (L2-L4) and hip (femoral neck)
• Low radiation dose
• Reports T-score and Z-score
• Indications for DEXA (when to scan):
  • Women >65 years (routine)
  • Men >70 years (routine)
  • Any fragility fracture at age >50
  • Patients on long-term corticosteroids (>3 months)
  • Secondary osteoporosis risk factors
  • Monitoring response to treatment (repeat at 1-2 years)
• Limitations: Cannot distinguish cortical vs trabecular bone; affected by osteoarthritis (spinal osteophytes give falsely high reading)

2. FRAX Score (Fracture Risk Assessment Tool)

• WHO-developed online calculator
• Calculates 10-year probability of major osteoporotic fracture (hip, wrist, humerus, vertebra) and hip fracture specifically
• Inputs: age, sex, weight, height, previous fracture, family history hip fracture, smoking, alcohol, steroids, rheumatoid arthritis, secondary osteoporosis, femoral neck BMD (optional)
• Does NOT require BMD - can be used in primary care without DEXA
• Used to decide who needs treatment (treatment threshold)
• High FRAX = treat even if T-score is not in osteoporotic range
• Limitation: does not account for number of previous fractures, falls risk, dose of corticosteroids

3. Blood Tests

4. Bone Turnover Markers

• Resorption markers: CTX (C-terminal telopeptide), NTX - reflect osteoclast activity
• Formation markers: P1NP (procollagen type I N-terminal propeptide), osteocalcin, bone ALP
• Used to: monitor treatment response, assess compliance, predict fracture risk
• Not routinely used for diagnosis

5. Plain X-ray

• Insensitive - osteoporosis NOT visible until 30-40% of bone mass is lost
• Signs on X-ray:
  • Decreased bone density - "washed-out" appearance
  • Singh index (trabecular pattern of proximal femur - Grades I-VI; Grade III or below suggests osteoporosis)
  • Vertebral fractures (wedge, biconcave, crush)
  • Cortical thinning of long bones
  • Pencil-point trabecular pattern in vertebrae

6. Singh Index (Proximal Femur Trabecular Pattern)

Grade III or below on Singh Index = clinical osteoporosis

---

9. MANAGEMENT

General Principles of Treatment

1. Identify and treat secondary causes
2. Lifestyle modification
3. Calcium and Vitamin D supplementation
4. Pharmacological treatment (anti-resorptive or anabolic)
5. Fall prevention
6. Fracture management

---

A. Lifestyle Modifications

• Weight-bearing exercise (walking, jogging, dancing) - stimulates bone formation
• Resistance (strengthening) training - improves muscle strength and balance
• Quit smoking
• Limit alcohol to <2 units/day
• Fall prevention: home hazard assessment, appropriate footwear, vision correction, physiotherapy

---

B. Calcium and Vitamin D (Foundation of Treatment)

• Calcium: 1200-1500 mg/day for adults over 50 (diet + supplements)
• Vitamin D: 800-1000 IU/day
• Vitamin D promotes calcium absorption from gut, reduces PTH, improves muscle function and balance
• Check 25-OH Vitamin D before starting treatment
• Vitamin D deficiency (level <50 nmol/L) must be corrected before starting bisphosphonates (risk of hypocalcaemia)

---

C. Pharmacological Treatment

1. Bisphosphonates (First-line Anti-resorptive)

• Postmenopausal osteoporosis
• Vertebral compression fracture in osteoporosis
• Non-vertebral fragility fracture
• Osteogenesis imperfecta
• Multiple myeloma
• Paget's disease
• Metastatic bone disease (IV bisphosphonates)
• Precollapse avascular necrosis (controversial)

• Take in the morning on empty stomach with full glass of water (200 mL)
• Stay upright for 30 minutes after taking
• Do not eat for 30 minutes
• (Prevents oesophageal irritation and improves absorption)

• GI: Oesophagitis, nausea, abdominal pain (oral BPs)
• Osteonecrosis of the jaw (ONJ) - rare; risk with dental extractions, IV BPs, cancer patients, steroids; prevention: dental review before starting IV BPs
• Atypical femur fractures (AFFs) - rare; after long-term use (>5 years); subtrochanteric or diaphyseal femur; prodromal thigh/groin pain; bilateral in 10-30%; "beaking" or cortical thickening on X-ray; mechanism: over-suppression of bone remodelling
• Acute phase reaction (IV zoledronic acid): fever, myalgia, flu-like illness in first 3 days
• Hypocalcaemia (especially IV; ensure Vitamin D replete first)
• Renal impairment (dose adjust if eGFR <35)

• After 3-5 years of oral or 3 years of IV bisphosphonates, reassess
• Patients with lower fracture risk can take a 2-5 year break
• Bisphosphonates remain in bone for years - benefit persists
• High-risk patients (previous hip/vertebral fracture) should continue

• Theoretically could impair healing (suppress resorption needed in early callus)
• BUT clinical evidence does NOT show impaired fracture healing
• HORIZON trial: Zoledronic acid started within 90 days of hip fracture surgery - no delay in healing, and mortality reduced 28%
• American Society of Bone and Mineral Research (ASBMR): bisphosphonates CAN be started in hospital after fracture - benefit overwhelms theoretical risk

---

2. Denosumab (Anti-RANKL Monoclonal Antibody)

• Mechanism: Human monoclonal antibody → binds and neutralizes RANKL → inhibits osteoclast formation, function, survival
• Route: Subcutaneous injection every 6 months (60 mg)
• Advantages over BPs:
  • No renal contraindication (safe in CKD)
  • Can use in patients who cannot tolerate oral BPs
  • Reversible (unlike BPs which stay in bone)
• Disadvantage: Rebound fracture risk if stopped suddenly - must switch to bisphosphonate when discontinuing
• Side effects: Hypocalcaemia, infection risk (especially skin - cellulitis), osteonecrosis of jaw (rare)
• Indications: Post-menopausal osteoporosis, male osteoporosis, cancer treatment-induced bone loss, GI intolerance to BPs, renal impairment

---

3. Teriparatide / PTH Analogues (Anabolic Agents)

• Teriparatide = recombinant PTH 1-34 fragment
• Mechanism: Intermittent PTH stimulates osteoblasts → net bone formation (anabolic effect)
  • Contrast: continuous high PTH (as in hyperparathyroidism) = bone LOSS; but pulsatile/intermittent PTH = bone GAIN
• Route: Daily subcutaneous injection (20 mcg)
• Duration: Maximum 24 months (lifetime limit due to osteosarcoma risk in rat studies)
• Indication: Severe osteoporosis, multiple vertebral fractures, failure of anti-resorptive therapy
• Best evidence for fracture healing - faster time to union in distal radius and pertrochanteric hip fractures
• After stopping: Must follow with anti-resorptive (bisphosphonate) to maintain gains
• Side effects: Nausea, leg cramps, hypercalcaemia, dizziness
• Contraindicated: Paget's disease, previous radiation to skeleton, hypercalcaemia, bone metastases

---

4. Romosozumab (Sclerostin Inhibitor - Dual Action!)

• Mechanism: Monoclonal antibody against sclerostin (a Wnt pathway inhibitor)
• Sclerostin is produced by osteocytes and inhibits bone formation
• Blocking sclerostin: increases bone formation AND decreases bone resorption (dual action)
• Route: Monthly subcutaneous injection for 12 months (210 mg/month)
• After 12 months: transition to anti-resorptive
• Indication: High-fracture-risk postmenopausal osteoporosis, especially patients with multiple vertebral fractures
• Black box warning: Increased risk of cardiovascular events (MI, stroke) - do NOT use in patients with prior MI or stroke
• Note: Despite anabolic benefits for OP, does NOT improve fracture healing in RCTs

---

5. Hormone Replacement Therapy (HRT / Estrogen)

• Reduces bone loss by inhibiting osteoclasts
• Reduces fracture risk (vertebral and non-vertebral)
• Use is limited due to risks: increased breast cancer, venous thromboembolism, cardiovascular events
• Still used in younger postmenopausal women (<60 years) who have vasomotor symptoms AND osteoporosis risk
• Not first-line for osteoporosis management alone

---

6. SERMs (Selective Estrogen Receptor Modulators)

• Raloxifene (Evista) - acts as estrogen agonist in bone and antagonist in breast and uterus
• Reduces vertebral fracture risk by ~50%
• Does NOT reduce hip fracture risk
• Reduces breast cancer risk
• Side effects: VTE (DVT/PE), hot flushes, leg cramps
• Used in: Postmenopausal osteoporosis (particularly if breast cancer risk present)

---

7. Calcitonin

• Inhibits osteoclasts via calcitonin receptor
• Weak anti-resorptive effect
• Main current use: Acute pain relief in vertebral compression fractures
• Nasal spray or injection
• Not first-line for fracture prevention

---

Summary Table of Osteoporosis Drugs

---

10. GLUCOCORTICOID-INDUCED OSTEOPOROSIS (GIOP)

• Most common cause of secondary osteoporosis - must know for exams!
• Risk directly proportional to dose AND duration of steroid therapy
• Bone loss is MOST RAPID in the first 3-6 months of steroid use
• Mechanisms:
  1. Reduced intestinal calcium absorption
  2. Increased renal calcium loss
  3. Osteoblast and osteocyte apoptosis (main mechanism) → impaired bone formation
  4. Suppression of gonadal hormones
  5. Inhibition of IGF-1

Prevention/Treatment of GIOP

• All patients on systemic steroids for >3 months should receive:
  • Calcium 1000-1500 mg/day + Vitamin D 800-1000 IU/day
  • Bisphosphonate (alendronate or risedronate) if:
    • Age >50 + T-score < -1.5 OR
    • Previous fragility fracture OR
    • High FRAX score
• DEXA scan at baseline and after 1 year
• Lowest effective steroid dose should always be used

---

11. ATYPICAL FEMUR FRACTURES (AFFs)

Features

• Subtrochanteric or femoral diaphyseal fracture (NOT the usual intertrochanteric/neck)
• Occurs after minimal or no trauma
• Prodromal symptoms: dull/aching pain in the thigh or groin for weeks/months BEFORE fracture
• Bilateral in 10-30% of cases
• Radiographic features:
  • Transverse (not spiral) fracture pattern
  • Lateral cortical beaking (localized periosteal thickening or "flare")
  • Minimal comminution
  • Medial spike

Mechanism

• Over-suppression of bone remodelling by long-term BPs → micro-damage accumulates → cannot be repaired → stress fracture

Management

• Stop bisphosphonate immediately
• Screen the opposite leg (bilateral risk)
• If prodromal pain without fracture: protected weight bearing, consider prophylactic IM nail
• If fracture: Intramedullary nail (NOT plate - high failure rate)
• Teriparatide (anabolic agent) may help healing

---

12. OSTEOPOROSIS AND FRACTURE FIXATION (Orthopaedic Specifics)

Challenges

• Poor bone quality - screws cut out, plates toggle, anchors fail
• Reduced pullout strength of implants
• Higher non-union rate
• Fracture patterns different (more comminuted, spiral fractures)

Strategies for Fixation in Osteoporotic Bone

1. Locking plates - screws lock into plate, create fixed-angle device; superior to conventional plates in osteoporotic bone
2. Cement augmentation - inject calcium phosphate or PMMA cement around implant to enhance fixation
3. Longer implants - distribute load over longer bone segment
4. More screws - increase purchase
5. Intramedullary devices preferred where possible (share load with bone)
6. Augmentation with bone graft or bone substitutes
7. Avoid stress risers (holes, notches) in the construct

Hip Fracture Specifics in Osteoporosis

• Femoral neck fracture (intracapsular): Hemi-arthroplasty or total hip replacement preferred in elderly (bone too poor for internal fixation, high failure rate of screws)
• Intertrochanteric fracture (extracapsular): Dynamic hip screw or intramedullary nail (cephalomedullary nail preferred for unstable patterns)
• Tip-Apex Distance (TAD): Sum of distances from tip of lag screw to apex of femoral head on AP and lateral views; TAD >25 mm = higher cutout risk

Vertebroplasty and Kyphoplasty

• Vertebroplasty: Percutaneous injection of PMMA cement into collapsed vertebral body
  • Immediate pain relief
  • Risk: cement leak (into canal or veins)
• Kyphoplasty (Balloon kyphoplasty): Balloon inserted first to create cavity and restore height, then cement injected at lower pressure
  • Better height restoration
  • Lower cement leak risk
  • Indicated for painful osteoporotic vertebral fractures not responding to conservative treatment

---

13. FRACTURE LIAISON SERVICES (FLS) / SECONDARY FRACTURE PREVENTION

• After a first fragility fracture, the risk of a second fracture is very high
• FLS/Orthogeriatric model: Systematic identification of all fragility fracture patients in hospital → investigation → treatment started before discharge
• The "Fracture Liaison Service" identifies patients, initiates DEXA, starts treatment
• DEXA should be considered for patients over 50 with ANY fragility fracture
• Key concept: "Own the fracture" - orthopaedic surgeon is responsible for initiating osteoporosis workup and treatment, not waiting for GP

---

14. TRANSIENT OSTEOPOROSIS OF THE HIP

• Self-limiting condition, most common in middle-aged men and third trimester pregnant women
• Painful hip with reduced ROM - can mimic AVN
• X-ray: periarticular osteopenia of femoral head (develops over weeks)
• MRI: bone marrow edema throughout femoral head and neck
• No collapse of femoral head (this distinguishes it from AVN)
• Management: Protected weight bearing, NSAIDs, bisphosphonates (in severe cases)
• Resolves spontaneously in 6-12 months
• Can recur in opposite hip

---

15. QUICK MEMORY AIDS FOR EXAM

T-Score Thresholds: "Normal, Openia, Porosis"

• > -1.0 = Normal (No problem)
• -1.0 to -2.5 = OstEOpenia (between 1 and 2.5)
• < -2.5 = OstEOPorosis (below 2.5)

Two Types of Osteoporosis:

• Type I = 1 (post-menopausal) = Trabecular = Vertebra + Wrist
• Type II = 2 (senile, age >70) = Both cortical + trabecular = Hip

Bisphosphonate Mechanism: "ABC"

• Acid resorption lacuna → BPs concentrate in bone
• Bone osteoclasts ingest BPs
• Cell (osteoclast) dies → no more resorption

Drugs Causing Osteoporosis: "CS-GAAH"

• Corticosteroids, SSRIs, GnRH agonists, Anticonvulsants, Aromatase inhibitors, Heparin

Atypical Femur Fracture mnemonic "LAT-BIM":

• Lateral cortical beaking, After long-term BPs, Transverse fracture, Bilateral in 10-30%, IM nail for treatment, Minimal trauma

---

SOURCES

• Rockwood and Green's Fractures in Adults, 10th Ed 2025 - Chapter 4: Osteoporosis, pp. 113-125
• Miller's Review of Orthopaedics, 9th Ed - Osteoporosis, pp. 42-45; Box I.1 Risk Factors
• Campbell's Operative Orthopaedics, 15th Ed 2026 - Bone Health and Fracture Management
• Henry's Clinical Diagnosis and Management by Laboratory Methods - Connective Tissue Disorders

---

Skeletal Fluorosis - Complete Guide for Orthopaedic Postgraduate Exams

---

1. DEFINITION

• Radiologically: Dense, sclerotic (hard-looking) bone
• Mechanically: Actually brittle, fragile bone prone to fracture
• Affects the entire skeleton but predominantly the axial skeleton (spine, pelvis)

---

2. FLUORIDE AND BONE - NORMAL vs. EXCESS

Normal role of fluoride

• At 0.5-0.8 mg/L in drinking water: prevents dental caries (protects enamel)
• At 1 mg/L: optimal level; fluoridated water standard

Toxic levels

---

3. EPIDEMIOLOGY

• Endemic disease - a major public health problem in parts of India, China, Africa, Middle East
• India - most affected districts: Andhra Pradesh (Nalgonda, Nellore, Prakasam), Punjab, Haryana, Karnataka, Kerala, Tamil Nadu, Rajasthan
• Worldwide: affects >200 million people in 25 countries
• Highest burden in developing nations with high-fluoride groundwater
• Three types of endemic fluorosis (by source):
  1. Drinking water type - most common; groundwater with naturally high fluoride
  2. Coal-burning type - burning high-fluoride coal indoors (China)
  3. Brick-tea type - drinking large quantities of tea made from old fluoride-rich leaves (China, Mongolia)

Other causes (Non-endemic)

• Industrial exposure: aluminium smelting, phosphate fertiliser factories, glass manufacturing
• Fluoride-containing medications (excessive sodium fluoride used historically for osteoporosis)
• Inhalant abuse (fluorinated hydrocarbons - difluoroethane)
• Drug-induced: Voriconazole (antifungal) causes fluoride-related periostitis
• Brewed tea consumption (especially strong fermented tea)

---

4. PATHOPHYSIOLOGY - How Fluoride Damages Bone

Step 1: Fluoride absorption

• Ingested fluoride rapidly absorbed from gut (stomach and small intestine)
• 99% of body fluoride stored in calcified tissues (bone and teeth)
• Bone acts as fluoride reservoir (fluoride half-life in bone = years)

Step 2: Fluoride replaces hydroxyl groups in bone mineral

• Normal bone mineral: Hydroxyapatite = Ca₁₀(PO₄)₆(OH)₂
• Fluoride substitutes OH⁻ → Fluorapatite = Ca₁₀(PO₄)₆F₂
• Fluorapatite is harder but more brittle than hydroxyapatite

Step 3: Effect on bone cells

• Stimulates osteoblasts → increased bone formation → osteosclerosis (early/moderate fluorosis)
• Inhibits osteoclasts (through NFATc1 gene inhibition) → impaired bone resorption
• Net result: bone accumulates in bulk BUT:
  • Bone quality is poor - collagen cross-linking is abnormal
  • Bone architecture is disrupted - trabecular structure lost
  • Results in dense but mechanically inferior, brittle bone

Step 4: Ligament/Tendon Ossification (Enthesopathy)

• Fluoride stimulates periosteal and entheseal new bone formation
• Leads to ossification of:
  • Posterior longitudinal ligament (PLL)
  • Ligamentum flavum
  • Interosseous membranes
  • Sacroiliac and iliolumbar ligaments
  • Tendons (calcification at insertions)

Step 5: Late changes - Osteoporosis phase

• In younger patients and early exposure: osteoporosis may occur (not osteosclerosis)
• Mechanism: fluoride at high doses can impair mineralization → osteomalacia-like picture
• Combination of osteoporosis + osteosclerosis in different parts of the same skeleton is characteristic

---

5. CLINICAL STAGES / CLASSIFICATION

WHO Classification (Most Used in Exams)

Stage 0 (Preclinical)

• No symptoms
• Fluoride accumulating in bone
• Urinary fluoride elevated
• X-ray normal

Stage 1 (Mild Skeletal Fluorosis)

• Intermittent stiffness and pain in joints
• Muscle weakness, fatigue
• X-ray: slight increase in bone density (early osteosclerosis)
• Still fully mobile

Stage 2 (Moderate Skeletal Fluorosis)

• Chronic joint pains and stiffness
• Osteosclerosis visible on X-ray, particularly in spine and pelvis
• Muscle wasting, osteoporosis coexists in some areas
• Calcification of ligaments visible
• Some limitation of spinal mobility

Stage 3 (Severe / Crippling Fluorosis)

• Severe limitation of joint movement and spinal rigidity
• Deformities: kyphosis, genu valgum, knock-knee (particularly in Andhra Pradesh sorghum belt variant)
• Neurological complications: spinal cord compression (myelopathy), radiculopathy
• Muscle atrophy, cachexia
• Patient may become wheelchair-bound or bedridden
• X-ray: marked osteosclerosis, loss of trabecular pattern, ligament ossification, massive spinal osteophytes

---

Hagen and Grinsberg Radiological Classification

---

6. CLINICAL FEATURES

Symptoms (in order of appearance)

1. Dental fluorosis - earliest sign; appears before skeletal changes
2. Back pain and joint pain (diffuse, chronic)
3. Morning stiffness of spine
4. Reduced spinal mobility (difficulty bending forward)
5. Paraesthesias - tingling, numbness in limbs (nerve root compression)
6. Weakness of limbs
7. Difficulty walking, climbing stairs
8. Deformities in advanced disease

Signs

• Mottled/pitted teeth (chalk-white → yellow → brown/black patches on enamel; incisors of upper jaw most prominent)
• Kyphosis (stooped posture from vertebral involvement)
• Genu valgum (knock-knee) - particularly in the sorghum-eating belt of India (AP/TN)
• Restricted range of motion - spine, hips, shoulders (bamboo spine appearance similar to ankylosing spondylitis)
• Neurological deficits: upper or lower motor neurone signs depending on level
  • Cervical involvement: myelopathy (spastic quadriparesis)
  • Thoracic involvement: paraparesis
  • Lumbar involvement: cauda equina syndrome (bladder, bowel, sexual dysfunction)
• Muscle wasting in late stages
• Enlarged and tender joints in some patients

Special Form - Genu Valgum Fluorosis (India)

• Seen in Andhra Pradesh and Tamil Nadu
• Affects young adults eating sorghum (jowar) as staple diet
• Sorghum promotes higher retention of ingested fluoride than rice
• Features: bilateral knock-knee deformity + osteoporosis of lower limbs
• Different from typical crippling fluorosis - less osteosclerosis, more osteoporosis

---

7. COMPARISON WITH LOOK-ALIKES

---

8. RADIOLOGY - DETAILED FEATURES (Very Important for Exams)

Plain X-Ray Changes (Progressive)

Spine (Most Characteristic Site)

• Increased bone density (osteosclerosis) - vertebral bodies appear "chalky white"
• Coarse trabecular pattern - "sandstorm" or "granular" appearance early
• Osteophytes - large, bridging; can mimic DISH
• Ossification of posterior longitudinal ligament (OPLL) - causes canal stenosis
• Ossification of ligamentum flavum - another cause of canal stenosis
• Ossification of ALL (anterior longitudinal ligament)
• Calcification of interspinous ligaments
• Paravertebral ossification (can look like ankylosing spondylitis)
• In extreme cases: complete fusion of vertebral column (true bamboo spine)

Pelvis

• Osteosclerosis of ilium, pubis, ischium
• Ossification of sacrotuberous, sacrospinous, and iliolumbar ligaments
• Bridging of pubic symphysis
• "Tigroid" or "chalky" pelvis appearance

Long Bones

• Cortical thickening (periosteal new bone formation)
• Narrowing of medullary canal
• Periosteal appositions (irregular new bone on outer surface)
• Ossification of interosseous membrane (between radius-ulna, tibia-fibula)
• In children: metaphyseal bands (dense transverse lines)
• Paradox: fragile bone despite appearing dense on X-ray

Ribs

• Thickened cortex
• Calcification of costal cartilages (can restrict chest expansion)

CT Findings

• Better delineation of canal stenosis (OPLL, ligamentum flavum ossification)
• Better assessment of cortical thickness and medullary narrowing
• Pre-surgical planning for decompression

MRI Findings

• Shows spinal cord compression and cord signal changes (myelopathy)
• OPLL and ligamentum flavum ossification compressing dura and cord
• High T2 signal in cord = myelomalacia (irreversible damage)
• Better soft tissue assessment than CT

Bone Scan (Tc-99m)

• Diffusely increased uptake throughout skeleton - especially axial
• Not specific but can demonstrate extent of disease

Key Radiological Differentials for Osteosclerosis (Memory Aid: "P-MALT-FO")

• Paget's disease
• Myeloma (sclerotic type - rare; POEMS syndrome)
• Acromegaly
• Lymphoma (Hodgkin's - ivory vertebra)
• Thalassaemia/sickle cell disease
• Fluorosis
• Osteopetrosis

---

9. INVESTIGATIONS

Confirmatory Test

• 24-hour urinary fluoride excretion - GOLD STANDARD for current fluoride exposure
  • Normal: <1 mg/24 hours
  • Fluorosis: >2-4 mg/24 hours (elevated)
• Serum fluoride: elevated (normal <0.05 mg/L; fluorosis >0.1 mg/L)

Blood Tests

Bone Biopsy (Rarely Needed)

• Shows: increased osteoid, fluorapatite crystals, abnormal collagen
• "Painted bones" - fluoride staining of bone matrix
• Not routinely done

Dental X-ray

• Mottled enamel - "chalk and brown patches" on incisors
• Erosion of enamel in severe cases

---

10. NEUROLOGICAL COMPLICATIONS (Critical Orthopaedic Points)

Spinal Canal Stenosis

• Most serious complication
• Caused by:
  1. OPLL (Ossification of Posterior Longitudinal Ligament)
  2. Ossification of Ligamentum Flavum (OLF) - especially thoracic spine
  3. Osteophyte encroachment into canal
  4. Cortical thickening of vertebral walls

Cervical Myelopathy

• Weakness and spasticity in all four limbs (quadriparesis)
• Hyperreflexia, clonus
• Lhermitte's sign (electric shock sensation on neck flexion)
• Bladder dysfunction in severe cases
• Surgical decompression required

Thoracic Myelopathy (due to OLF)

• Most unique to fluorosis - thoracic OLF is characteristic
• Paraparesis (lower limb spasticity)
• Sensory level
• Bowel and bladder dysfunction

Lumbar Canal Stenosis

• Neurogenic claudication
• Cauda equina syndrome if severe

Peripheral Nerve Compression

• Radiculopathy from foraminal stenosis
• Less common

---

11. ORTHOPAEDIC SURGICAL MANAGEMENT

Conservative Management (for mild-moderate disease)

• Remove source of fluoride exposure (most important step - change water source or defluoridate)
• Adequate nutrition: Calcium (1200-1500 mg/day), Vitamin C, Vitamin D
• Calcium inhibits fluoride absorption from gut (calcium binds fluoride → insoluble calcium fluoride → excreted)
• Antioxidants: Vitamin C, E (reduce free radical damage from fluoride)
• Physiotherapy for range of motion maintenance
• Analgesics for pain
• Joint support devices, orthoses

Surgical Indications

1. Spinal cord compression (myelopathy - urgent)
2. Severe spinal canal stenosis with neurological deficit
3. Joint deformities requiring correction (genu valgum)
4. Fractures through osteoporotic fluorotic bone

Spinal Surgery - Key Points for Exams

Cervical Decompression

• Anterior cervical decompression and fusion (ACDF) or posterior laminectomy
• OPLL in cervical spine: anterior approach preferred (ACDF or corpectomy)
• Risk: dural ossification - dura may be fused to OPLL; high risk of CSF leak

Thoracic Decompression for OLF

• Posterior approach: laminectomy or laminotomy
• Risk: dural adhesion to ossified ligamentum flavum
• "Floating island" technique - create window in ossified ligament without peeling it from dura
• High surgical risk; requires specialized spine surgery

Lumbar Decompression

• Standard laminectomy or microdecompression
• Technically challenging due to dense, brittle bone
• Drills must be used carefully - bone shatters unexpectedly

Total Knee Arthroplasty (TKA) in Fluorosis - Special Considerations

• Done for end-stage knee disease from fluorosis-related arthropathy
• Intraoperative paradox: X-ray shows dense sclerotic bone → surgeon expects hard bone → actually extremely brittle, fragile bone that fractures easily
• High risk of:
  • Periprosthetic fracture during surgery
  • Canal narrowing makes intramedullary instrumentation difficult
  • Cement fixation may be unreliable in dense bone
• Preoperative planning must account for this paradox

---

12. PREVENTION (Public Health - Important in Indian Context)

Primary Prevention

1. Change water source - find low-fluoride surface water (<1 mg/L)
2. Defluoridation of water - Nalgonda technique (developed by NEERI, Nagpur):
   • Add lime and alum in sequence
   • Flocculation → Sedimentation → Filtration
   • Reduces fluoride to safe levels
3. Fluoride filters - household level (bone char, activated alumina)
4. Food modification: Rice-based diet retains less fluoride than sorghum (relevant in AP/TN)

Secondary Prevention

• Regular surveillance (urine fluoride testing) in endemic areas
• DEXA/X-ray screening in at-risk populations
• Early treatment to prevent progression

National Programme for Prevention and Control of Fluorosis (NPPCF)

• Government of India programme
• Covers surveillance, IEC (Information Education Communication), referral services
• District and village level fluorosis monitoring

---

13. DIFFERENTIAL DIAGNOSIS SUMMARY

"Dense bones on X-ray" - What else can cause it?

---

14. QUICK SUMMARY TABLE

---

15. MEMORY AIDS FOR EXAM

Fluoride water levels: "1-3-10"

• 1 mg/L = safe (prevents caries)
• 3 mg/L = skeletal fluorosis
• 10 mg/L = crippling fluorosis

Ligaments ossified in fluorosis: "PALL-I"

• Posterior longitudinal ligament
• Anterior longitudinal ligament
• Ligamentum flavum
• Lumbosacral/iliolumbar ligaments
• Interosseous membrane (radius-ulna, tibia-fibula)

Features of Crippling Fluorosis: "3S"

• Spinal rigidity (bamboo-like)
• Spinal cord compression (myelopathy)
• Skeletal deformity (kyphosis, genu valgum)

Fluorosis vs Ankylosing Spondylitis (exam classic):

---

SOURCES

• Grainger & Allison's Diagnostic Radiology - Fluorosis, Metabolic Bone Diseases
• Park's Textbook of Preventive and Social Medicine - Endemic Fluorosis, pp. 739-740
• Harrison's Principles of Internal Medicine, 22nd Ed 2025 - Fluoride, Trace Elements
• Radiopaedia - Fluorosis
• International Journal of Research in Orthopaedics - Diagnosis and Management of Skeletal Fluorosis
• Frontiers in Surgery 2026 - TKA in Skeletal Fluorosis